China Universal Asset Management Company’s SpringWorks Therapeutics SWTX Stock Holding History

China Universal Asset Management Company’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,031	Closed	-$663K	–	496
2025 Q1	$663K	Sell	15,031 -742	-5%	-$34.2K	0.06%	217
2024 Q4	$570K	Buy	15,773 +1,488	+10%	+$52K	0.05%	238
2024 Q3	$458K	Buy	14,285 +5,582	+64%	+$209K	0.05%	232
2024 Q2	$328K	Sell	8,703 -5,491	-39%	-$231K	0.05%	180
2024 Q1	$699K	Buy	14,194 +6,957	+96%	+$322K	0.09%	153
2023 Q4	$264K	Buy	7,237 +5,625	+349%	+$147K	0.05%	184
2023 Q3	$37.3K	Buy	1,612 +792	+97%	+$21.7K	0.01%	249
2023 Q2	$21.5K	Sell	820 -27	-3%	-$710	0.01%	260
2023 Q1	$21.8K	Buy	847 +213	+34%	+$6.22K	0.01%	208
2022 Q4	$16.5K	Buy	634 +171	+37%	+$4.21K	0.01%	187
2022 Q3	$13K	Buy	+463	New	+$13.3K	0.01%	185

Other funds holding SWTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

China Universal Asset Management Company's SWTX Position: Q2 2025 in Review

China Universal Asset Management Company sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 15,031 shares — an estimated $663K sold.

China Universal Asset Management Company first reported a position in SWTX in Q3 2022 and held it in 11 quarters. The position peaked at $699K in Q1 2024. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

China Universal Asset Management Company reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
China Universal Asset Management Company sold 15,031 SpringWorks Therapeutics shares in Q2 2025, an estimated $663K.
China Universal Asset Management Company first reported a position in SpringWorks Therapeutics in Q3 2022 and held it in 11 quarters.
China Universal Asset Management Company's SpringWorks Therapeutics position peaked at $699K in Q1 2024.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.